Corteva upgraded to Overweight with $17 price target

KeyBanc raised its rating on Corteva to Overweight and set a new price target of $17. The stock was trading at $13.91 in pre‑market trading, up about 12.3%. KeyBanc said the upgrade reflects a strong balance sheet, attractive valuation and growth prospects, including $800 million of new product revenue expected by 2029.

KeyBanc expects the $17 target represents roughly 22.2% upside from the October 6 close, which could drive buying interest in the shares.

Sources